Exodus Point Capital Management, LP Clearside Biomedical, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.13 - $1.83 $14,441 - $23,387	-12,780 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$1.3 - $2.49 $16,614 - $31,822	12,780 New	12,780 $19,000
Q1 2022 May 13, 2022	SELL	$1.35 - $2.88 $39,669 - $84,628	-29,385 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.72 - $5.72 $16,048 - $33,748	5,900 Added 25.12%	29,385 $81,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $113,432 - $169,092	23,485 New	23,485 $141,000

Q2 2021 Aug 16, 2021	SELL	$2.32 - $5.38 $46,133 - $106,981	-19,885 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.24 - $4.25 $44,542 - $84,511	19,885 New	19,885 $49,000

15.1M

22.7K

200

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $77M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.